363-23-5 (13,14-二氢-15-酮前列腺素e2,13,14-Dihydro-15-ketoPGE2)

13,14-二氢-15-酮前列腺素 E2 溶液;13,14-二氢-15-酮前列腺素e2;

Prost-5-en-1-oic acid,11-hydroxy-9,15-dioxo-, (5Z,11a)-;(Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid;13,14-dihydro-15-keto Prostaglandin E2;13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps MS Standard;13,14-Dihydro-15-keto-PGE2;15-Keto-13,14-dihydro-PGE2;15-keto-13,14-dihydroprostaglandin E2;dhk-PGE2;PGEM;Prost-5-en-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11alpha)-;PGE2, 13,14-dihydro15-oxo;PGE2 13,14-dihydro;11-alpha-hydroxy-9,15-dioxoprost-5-enoic acid;363-23-5;13,14-DIHYDRO-15-KETOPROSTAGLANDINE2;13,14-Dihydro-15-ketoPGE2;CAS_363-23-5;SR-01000946429;363-23-5 (unlabeled);13,14-Dihydro-15-keto PGE2;13,14-Dihydro-15-ketoprostaglandin E2;13,14-dihydro-15-oxo-prostaglandin E2;SCHEMBL13958223;C04671;Prostaglandin EM;PD020584;LMFA03010031;(5Z)-(15S)-11alpha-Hydroxy-9,15-dioxoprostanoate;CUJMXIQZWPZMNQ-XYYGWQPLSA-N;13,14-dihydro-15-keto Prostaglandin E2-d4;13,14-dihydro-15-keto Prostaglandin E2 Lipid Maps(R) MS Standard;KH(2)PGE(2);Q27098097;SR-01000946429-1;BDBM82093;DTXSID30869647;11-alpha-hydroxy-9,15-dioxoprost-5-enoate;HMS3648H15;13,14-dihydro-15-keto-Prostaglandin E2;9,15-dioxo-11R-hydroxy-5Z-prostenoic acid;(5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoic acid;CHEBI:15550;(5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate;G91320;

MFCD00135217

CUJMXIQZWPZMNQ-XYYGWQPLSA-N

1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,16-17,19,23H,2-3,5-6,8-14H2,1H3,(H,24,25)/b7-4-/t16-,17-,19-/m1/s1

O[C@@H]1CC([C@H](C/C=C\CCCC(=O)O)[C@H]1CCC(CCCCC)=O)=O